Navigation Links
Newest HIV drugs should be used with FUZEON(R)

Data presented at IAS build a compelling case for FUZEON (enfuvirtide, formerly known as T-20) to be combined with the newest drugs to give patients facing resistance their best chance of achieving undetectable viral load ?the optimal treatment goal for all people living with HIV.

"Undetectable viral load should be the ultimate treatment goal for all triple-class experienced patients. FUZEON combined with the latest drugs now makes this much more achievable," explained Dr Mike Youle the Royal Free Hospital, London. "We are seeing a consistent FUZEON effect with these new drugs and I believe these data must change the way we manage triple class experienced patients facing HIV resistance and failing to reach undetectable viral load."

Studies presented this week show that when FUZEON was given in combination with the novel HIV medication, tipranavir, an impressive 70% of FUZEON naïve patients achieved a ten-fold reduction in their viral load and furthermore they also had double the increase in immune cell count1, compared to patients receiving tipranavir/r without FUZEON.

This adds to the growing body of evidence for the powerful "FUZEON effect" which has been seen across the RESIST 1 & 2, POWER 1 & 2 and TORO 1 & 2 studies, where adding FUZEON was seen to almost double the number of patients reaching undetectable, when combined with one of the latest boosted PIs such as lopinavir/r, tipranavir/r or TMC 114/r.

Doctors underestimate significant "FUZEON effect"

Surprisingly, of the 560 doctors surveyed onsite this week at the IAS conference, three quarters (75%) underestimated the "FUZEON effect" seen in both RESIST2 and POWER3 studies.

Latest data adds to growing Body of Evidence ?Latest Boosted Protease Inhibitors (lopinavir/r, tipranavir/r and TMC 114/r) all work best in combination with FUZEON

RESIST Phase III tipranavir trials
Over 24 weeks, almost double the proportion of patients who received
'"/>

Source:Ketchum


Page: 1 2 3

Related biology news :

1. Molecular machine may lead to new drugs to combat human diseases
2. Researchers identify target for cancer drugs
3. MetaChip provides quick, efficient toxicity screening of potential drugs
4. Newly discovered pathway might help in design of cancer drugs
5. UNC launches study of liver injury caused by drugs
6. Findings have implications for tracking disease, drugs at the molecular level
7. Future diabetes drugs may target new protein interaction
8. UCLA study assesses cost-effectiveness of Hepatitis B drugs
9. Sponges as drugs
10. Recombinant DNA technology may enable oral, rather than injectable, delivery of protein drugs
11. FDA approves more generic AIDS drugs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Newest HIV drugs should used with FUZEON

(Date:7/31/2015)... SHENZHEN, China , 31 de julho de 2015 ... Genômica (ICG-10, www.icg-10.org ) será realizada pela BGI de ... China . A conferência está ... inauguração em 2006, a ICG se tornou uma das ... e um dos encontros científicos mais dinâmicos, entusiastas e ...
(Date:7/31/2015)... 2015 La 10 th International Conference on ... BGI del 22 al 25 de octubre de 2015 en ... la conferencia celebra su décimo aniversario. Desde su inauguración en ... las reuniones anuales más influyentes del mundo en el campo ... entusiastas y mejores a nivel científico. ICG-10 ...
(Date:7/31/2015)... --NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market and creator of the Wocket® smart ... for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND SYSTEM ... crypto-currencies such as Bitcoin into the consumer market of ... manage all payments.  The technology manages ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... Gee MD MPH FACOG, Assistant Professor, LSU Health Sciences ... has been chosen to receive a Recognition of Distinction ... from the Association of Maternal & Child Health (MCH) ... contributions to the health of women, children, and families ...
... (ABC) has chosen Andreas Rmpp (38) and Sabine Guenther ... Rmpp and Guenther are the lead authors of a paper ... by 1,000 euros, was created by Springer to honor exceptional ... Best Paper Award has been given since 2005. Mass ...
... Medical Center in Salt Lake City is part of ... new evidence-based clinical guidelines used by physicians worldwide for ... the most common cardiovascular diseases in the United States. ... Clinic at Intermountain Medical Center, says the new guidelines ...
Cached Biology News:LSUHSC's Gee honored for improving health of women, children and families 2ABC Best Paper Award 2011 goes to Andreas Römpp and Sabine Guenther 2New guidelines developed for improved DVT diagnosis 2
(Date:8/27/2015)... ... 27, 2015 , ... Proove Biosciences, a commercial and ... of genetics and hypertension at the International Academy of Cardiology Annual ... Canada. The event, which boasts an extensive overview of the latest research developments ...
(Date:8/26/2015)... , ... August 26, 2015 , ... ... increasing its investment in the development and manufacture of highly valued cardiac markers ... company’s scientific team's extensive expertise with protein chemistry has led to the development ...
(Date:8/26/2015)... and BEIJING , August 26, 2015 ... Impressive Acheivements  DiaCardio wins 1 st place  ... The competition, led in Israel by venture ... startups from countries including the US, China , ... Latin America .  Impressive achievement for ...
(Date:8/26/2015)... ... ... PRC Clinical, a Clinical Trial Management Expert CRO, will be ... California. The Clinical Trial Management Expert CRO seeks to introduce more California-based sponsors to ... , Stem Cell Meeting on the Mesa on October 7-9 in ...
Breaking Biology Technology:Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3
... - The Department of Commerce (Commerce) has qualified five ... Angel Investor and Venture Fund Tax Credit Programs. , ... crucial investments, we are helping to turn these great ... , ,The Angel Investor and Venture Fund Tax ...
... prices. Always low prices. When it comes to consumer goods, ... selection and fanatical commitment to low prices, Wal-Mart is the ... Wal-Mart is the place to get it. , ,The company ... unfavorable attention lately. Union and activist groups have successfully derailed ...
... president of an international corporation used to take a lifetime ... PC, strong entrepreneurial spirit, and in less than 30 days. ... professionals. It's estimated that 80 percent of businesses fail within ... type, you might be discouraged by such an estimate. ...
Cached Biology Technology:Five technology companies qualify for investor tax credits 2Wal-Mart: How low can you go? 2Wal-Mart: How low can you go? 3Wal-Mart: How low can you go? 430 days to success: Three simple steps to create your own international startup 230 days to success: Three simple steps to create your own international startup 330 days to success: Three simple steps to create your own international startup 430 days to success: Three simple steps to create your own international startup 5
GRADIENT MAKER, 30 ML, 1 EA. Category: Protein Vertical Instruments....
... G. Butcher (1998). • The major histocompatibility ... in the immunology area. There is great ... and in their function as antigen-presenting molecules. ... the prospect of tackling biochemical and genetic ...
DALT GRADIENT MAKER,230V, 1 EA. Category: 2D DALT Systems....
actin from rabbit muscle Cell Biology Cytoskeletal Probes Actin and Actin Probes...
Biology Products: